Total Payments
$871.33
2024 Payments
$67.35
Companies
7
Transactions
10
Medicare Patients
1,385
Medicare Billing
$100,501
Payment Breakdown by Category
Travel$541.39 (62.1%)
Food & Beverage$166.26 (19.1%)
Education$163.68 (18.8%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $541.39 | 2 | 62.1% |
| Food and Beverage | $166.26 | 3 | 19.1% |
| Education | $163.68 | 5 | 18.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PROCEPT BioRobotics Corporation | $541.39 | 2 | $0 (2023) |
| CONMED Corporation | $122.37 | 1 | $0 (2023) |
| PFIZER INC. | $63.00 | 3 | $0 (2024) |
| Astellas Pharma US Inc | $51.99 | 1 | $0 (2022) |
| UROVANT SCIENCES INC | $48.69 | 1 | $0 (2022) |
| KOELIS Inc. | $25.35 | 1 | $0 (2024) |
| C. R. Bard, Inc. & Subsidiaries | $18.54 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $67.35 | 3 | PFIZER INC. ($42.00) |
| 2023 | $703.30 | 5 | PROCEPT BioRobotics Corporation ($541.39) |
| 2022 | $100.68 | 2 | Astellas Pharma US Inc ($51.99) |
All Payment Transactions
10 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/03/2024 | PFIZER INC. | ORGOVYX (Drug) | Education | In-kind items and services | $21.00 | General |
| Category: ONCOLOGY | ||||||
| 06/26/2024 | PFIZER INC. | ORGOVYX (Drug) | Education | In-kind items and services | $21.00 | General |
| Category: ONCOLOGY | ||||||
| 02/20/2024 | KOELIS Inc. | Trinity (Device) | Food and Beverage | In-kind items and services | $25.35 | General |
| Category: Urology | ||||||
| 10/19/2023 | CONMED Corporation | AIRSEAL (Device) | Food and Beverage | In-kind items and services | $122.37 | General |
| Category: GENERAL SURGERY | ||||||
| 05/17/2023 | PFIZER INC. | ORGOVYX (Drug) | Education | In-kind items and services | $21.00 | General |
| Category: ONCOLOGY | ||||||
| 04/24/2023 | PROCEPT BioRobotics Corporation | AQUABEAM ROBOTIC SYSTEM (Device) | Travel and Lodging | In-kind items and services | $512.39 | General |
| Category: Urology | ||||||
| 04/24/2023 | PROCEPT BioRobotics Corporation | AQUABEAM ROBOTIC SYSTEM (Device) | Travel and Lodging | In-kind items and services | $29.00 | General |
| Category: Urology | ||||||
| 03/08/2023 | C. R. Bard, Inc. & Subsidiaries | Bard Urinary Drainage Bag (Device) | Food and Beverage | In-kind items and services | $18.54 | General |
| Category: Urology | ||||||
| 03/04/2022 | Astellas Pharma US Inc | — | Education | In-kind items and services | $51.99 | General |
| 02/22/2022 | UROVANT SCIENCES INC | GEMTESA (Drug) | Education | In-kind items and services | $48.69 | General |
| Category: Urology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 467 | 547 | $152,266 | $31,169 |
| 2022 | 7 | 314 | 332 | $112,944 | $20,498 |
| 2021 | 8 | 310 | 360 | $147,567 | $25,388 |
| 2020 | 7 | 294 | 332 | $141,113 | $23,446 |
Total Patients
1,385
Total Services
1,571
Medicare Billing
$100,501
Procedure Codes
37
All Medicare Procedures & Services
37 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 129 | 150 | $28,382 | $6,944 | 24.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 60 | 72 | $20,824 | $4,888 | 23.5% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Facility | 2023 | 62 | 83 | $27,757 | $4,657 | 16.8% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2023 | 35 | 42 | $21,272 | $4,395 | 20.7% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Facility | 2023 | 50 | 59 | $4,980 | $2,437 | 48.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 20 | 20 | $9,395 | $1,920 | 20.4% |
| 55700 | Biopsy of prostate gland | Facility | 2023 | 19 | 19 | $17,407 | $1,726 | 9.9% |
| 52310 | Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | Facility | 2023 | 15 | 15 | $7,735 | $1,669 | 21.6% |
| 74420 | Imaging of urinary tract following injection of a contrast agent | Facility | 2023 | 47 | 57 | $4,560 | $1,035 | 22.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2023 | 16 | 16 | $5,104 | $865.20 | 17.0% |
| 76998 | Ultrasonic guidance during surgery | Facility | 2023 | 14 | 14 | $4,850 | $632.80 | 13.0% |
| 52356 | Crushing of stone of ureter with insertion of stent using an endoscope | Facility | 2022 | 13 | 13 | $21,482 | $4,147 | 19.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 48 | 50 | $10,000 | $2,522 | 25.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 31 | 32 | $9,984 | $2,374 | 23.8% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Facility | 2022 | 38 | 40 | $16,864 | $2,322 | 13.8% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2022 | 24 | 26 | $18,035 | $2,119 | 11.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 41 | 43 | $8,796 | $1,767 | 20.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 21 | 24 | $7,488 | $1,577 | 21.1% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2022 | 25 | 29 | $14,210 | $1,303 | 9.2% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Facility | 2022 | 24 | 24 | $1,920 | $1,206 | 62.8% |
| 74420 | Imaging of urinary tract following injection of a contrast agent | Facility | 2022 | 37 | 39 | $3,205 | $702.96 | 21.9% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 12 | 12 | $960.00 | $459.06 | 47.8% |
| 52356 | Crushing of stone in urinary duct (ureter) with stent using an endoscope | Facility | 2021 | 23 | 23 | $42,066 | $7,595 | 18.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 84 | 96 | $18,738 | $4,261 | 22.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 50 | 57 | $17,460 | $4,042 | 23.2% |
About Dr. Jonas Gricius, M.D
Dr. Jonas Gricius, M.D is a Urology healthcare provider based in Bangor, Maine. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/09/2008. The National Provider Identifier (NPI) number assigned to this provider is 1659534782.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jonas Gricius, M.D has received a total of $871.33 in payments from pharmaceutical and medical device companies, with $67.35 received in 2024. These payments were reported across 10 transactions from 7 companies. The most common payment nature is "Travel and Lodging" ($541.39).
As a Medicare-enrolled provider, Gricius has provided services to 1,385 Medicare beneficiaries, totaling 1,571 services with total Medicare billing of $100,501. Data is available for 4 years (2020–2023), covering 37 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Other Specialties Student in an Organized Health Care Education/Training Program, Urology
- Location Bangor, ME
- Active Since 07/09/2008
- Last Updated 04/02/2020
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1659534782
Products in Payments
- AQUABEAM ROBOTIC SYSTEM (Device) $541.39
- AIRSEAL (Device) $122.37
- ORGOVYX (Drug) $63.00
- GEMTESA (Drug) $48.69
- Trinity (Device) $25.35
- Bard Urinary Drainage Bag (Device) $18.54
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.